🔗 Visit the ClinicalTrials.gov page for NCT00803829
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. | Gut | 2005 | 2.29 |
| 2 | Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. | J Appl Microbiol | 2008 | 1.91 |
| 3 | Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. | Gut | 2004 | 1.63 |
| 4 | Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. | Clin Infect Dis | 2004 | 1.33 |
| 5 | Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. | Gut | 2004 | 1.26 |
| 6 | Prebiotics, synbiotics and inflammatory bowel disease. | Mol Nutr Food Res | 2008 | 0.82 |